Atlas Trials

Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS

Clinical trial NCT02797015 · COMPLETED

Trial details

NCT number
NCT02797015
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2016-06-23
Primary completion
2017-10-20
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.